分析波兰社会保险机构(ZUS)就波兰目前的多发性硬化症药物治疗方案实施前后与多发性硬化症患者有关的丧失工作能力的决定

IF 0.3 Q4 REHABILITATION
D. Lachman, Piotr Winciunas, J. Lorkowski, Piotr Kupidurski, Zuzanna Komosińska
{"title":"分析波兰社会保险机构(ZUS)就波兰目前的多发性硬化症药物治疗方案实施前后与多发性硬化症患者有关的丧失工作能力的决定","authors":"D. Lachman, Piotr Winciunas, J. Lorkowski, Piotr Kupidurski, Zuzanna Komosińska","doi":"10.36740/abal202204106","DOIUrl":null,"url":null,"abstract":"Aim: The aim of the study was to analyse the decisions on incapacity for work issued at the Polish Social Insurance Institution (ZUS) in the years 2009-2011 and 2016-2018 in relation to people with MS, before and after the introduction of MS drug treatment programmes in Poland, which in connection with the application for rehabilitation or disability pension were examined by a ZUS certifying doctor or ZUS medical board. Materials and Methods: The analysis covered 100 cases, in which in the years 2009-2011 and 2016-2018, in connection with the application for a rehabilitation benefit or a disability pension, a ZUS certifying doctor or ZUS medical board issued a decision on incapacity for work in relation to the same person with the diagnosed SM. Statistical analysis was performed using IBM SPSS Statistics. Results: There were 20% less medical decisions confirming deterioration of health condition related to persons covered by drug programmes compared to the group of persons not participating in these programmes. The asymptotic (two-sided) significance of the cross-tabulation association measure was p = 0.053. In the case of an increase in the number of no-change-in-disability decisions in the group of people covered by the drug programme, the asymptotic (two-sided) significance of the cross-tabulation association measure was p = 0.087. Conclusions: 1. The introduction of immunological therapy that modifies the natural course of multiple sclerosis in patients under the MS drug treatment programmes has significantly reduced the development of their motor disability. 2. As a result, people who have become incapable of work due to this disease have maintained their job or have returned to work, which is particularly important for young patients who are likely to remain economically active for many years to come. 3. Such measures have a significant impact on reducing the number of benefits from the social insurance system.","PeriodicalId":42213,"journal":{"name":"Acta Balneologica","volume":"1 1","pages":""},"PeriodicalIF":0.3000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Analysis of Decisions on Incapacity for Work Issued at the Polish Social Insurance Institution (ZUS) in Relation to Persons with Multiple Sclerosis Before and After the Introduction of Current Drug Treatment Programmes for Multiple Sclerosis in Poland\",\"authors\":\"D. Lachman, Piotr Winciunas, J. Lorkowski, Piotr Kupidurski, Zuzanna Komosińska\",\"doi\":\"10.36740/abal202204106\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Aim: The aim of the study was to analyse the decisions on incapacity for work issued at the Polish Social Insurance Institution (ZUS) in the years 2009-2011 and 2016-2018 in relation to people with MS, before and after the introduction of MS drug treatment programmes in Poland, which in connection with the application for rehabilitation or disability pension were examined by a ZUS certifying doctor or ZUS medical board. Materials and Methods: The analysis covered 100 cases, in which in the years 2009-2011 and 2016-2018, in connection with the application for a rehabilitation benefit or a disability pension, a ZUS certifying doctor or ZUS medical board issued a decision on incapacity for work in relation to the same person with the diagnosed SM. Statistical analysis was performed using IBM SPSS Statistics. Results: There were 20% less medical decisions confirming deterioration of health condition related to persons covered by drug programmes compared to the group of persons not participating in these programmes. The asymptotic (two-sided) significance of the cross-tabulation association measure was p = 0.053. In the case of an increase in the number of no-change-in-disability decisions in the group of people covered by the drug programme, the asymptotic (two-sided) significance of the cross-tabulation association measure was p = 0.087. Conclusions: 1. The introduction of immunological therapy that modifies the natural course of multiple sclerosis in patients under the MS drug treatment programmes has significantly reduced the development of their motor disability. 2. As a result, people who have become incapable of work due to this disease have maintained their job or have returned to work, which is particularly important for young patients who are likely to remain economically active for many years to come. 3. Such measures have a significant impact on reducing the number of benefits from the social insurance system.\",\"PeriodicalId\":42213,\"journal\":{\"name\":\"Acta Balneologica\",\"volume\":\"1 1\",\"pages\":\"\"},\"PeriodicalIF\":0.3000,\"publicationDate\":\"2022-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Acta Balneologica\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.36740/abal202204106\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"REHABILITATION\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Balneologica","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36740/abal202204106","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"REHABILITATION","Score":null,"Total":0}
引用次数: 0

摘要

目的:本研究的目的是分析2009-2011年和2016-2018年波兰社会保险机构(ZUS)在波兰引入多发性硬化症药物治疗方案之前和之后发布的与多发性硬化症患者有关的丧失工作能力的决定,这些决定与康复或残疾养恤金的申请有关,由ZUS认证医生或ZUS医学委员会审查。材料和方法:该分析涵盖了2009-2011年和2016-2018年期间的100个案例,其中与康复福利或残疾养恤金的申请有关,ZUS认证医生或ZUS医疗委员会对诊断为SM的同一个人发布了关于丧失工作能力的决定。采用IBM SPSS Statistics进行统计学分析。结果:与不参加这些方案的人群相比,药物方案所涵盖的人群确认健康状况恶化的医疗决定减少了20%。交叉表关联测量的渐近(双侧)显著性为p = 0.053。在药物计划所涵盖的人群中,残疾决定不变的人数增加的情况下,交叉表关联测量的渐近(双侧)显著性为p = 0.087。结论:1。免疫疗法的引入改变了多发性硬化症患者在多发性硬化症药物治疗方案下的自然病程,显著减少了他们运动障碍的发展。2. 因此,由于这种疾病而丧失工作能力的人仍能保住工作或重返工作岗位,这对可能在未来许多年里继续从事经济活动的年轻患者尤其重要。3.这些措施对减少社会保险制度福利的数量有重大影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Analysis of Decisions on Incapacity for Work Issued at the Polish Social Insurance Institution (ZUS) in Relation to Persons with Multiple Sclerosis Before and After the Introduction of Current Drug Treatment Programmes for Multiple Sclerosis in Poland
Aim: The aim of the study was to analyse the decisions on incapacity for work issued at the Polish Social Insurance Institution (ZUS) in the years 2009-2011 and 2016-2018 in relation to people with MS, before and after the introduction of MS drug treatment programmes in Poland, which in connection with the application for rehabilitation or disability pension were examined by a ZUS certifying doctor or ZUS medical board. Materials and Methods: The analysis covered 100 cases, in which in the years 2009-2011 and 2016-2018, in connection with the application for a rehabilitation benefit or a disability pension, a ZUS certifying doctor or ZUS medical board issued a decision on incapacity for work in relation to the same person with the diagnosed SM. Statistical analysis was performed using IBM SPSS Statistics. Results: There were 20% less medical decisions confirming deterioration of health condition related to persons covered by drug programmes compared to the group of persons not participating in these programmes. The asymptotic (two-sided) significance of the cross-tabulation association measure was p = 0.053. In the case of an increase in the number of no-change-in-disability decisions in the group of people covered by the drug programme, the asymptotic (two-sided) significance of the cross-tabulation association measure was p = 0.087. Conclusions: 1. The introduction of immunological therapy that modifies the natural course of multiple sclerosis in patients under the MS drug treatment programmes has significantly reduced the development of their motor disability. 2. As a result, people who have become incapable of work due to this disease have maintained their job or have returned to work, which is particularly important for young patients who are likely to remain economically active for many years to come. 3. Such measures have a significant impact on reducing the number of benefits from the social insurance system.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Acta Balneologica
Acta Balneologica REHABILITATION-
自引率
66.70%
发文量
58
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信